Paper Details

  1. Home
  2. Paper Details

Efficacy and tolerance of nisoldipine VS propranolol in patients with essential hypertension.

Author: BednarzB, BudajA, CeremuzyńskiL, ChamiecT, KłośJ, PietrzykowskaH, ZaleskaT

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Nisoldipine was found to be safe and effective in treating mild essential hypertension. It reduced mean systolic and diastolic blood pressure similarly to propranolol with few and mild side effects.
Paper Details　
Original Abstract of the Article :
Fifty patients with essential hypertension grade I/II. (WHO) were treated with Nisoldipine (BAY K 5552) or Propranolol for 12 weeks in a single blind, randomised trial. Both drugs similarly reduced mean systolic and diastolic blood pressure. Side effects were rare and usually mild. We conclude that ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2132424

データ提供：米国国立医学図書館（NLM）

Nisoldipine vs. Propranolol: A Battle of Blood Pressure Control

The realm of [hypertension treatment] is constantly evolving as researchers seek optimal solutions for managing high blood pressure. This study compares the efficacy of two commonly used drugs, [nisoldipine] and [propranolol], in treating [essential hypertension]. The authors conducted a [single-blind, randomized trial] involving [50 patients], assessing the effectiveness of both drugs over a [12-week] period. Their findings demonstrate that both drugs effectively reduced blood pressure.

A Level Playing Field: Nisoldipine and Propranolol Show Similar Efficacy

The results of this study, based on [50 participants] over a [12-week] period, indicate that both [nisoldipine] and [propranolol] were equally effective in lowering systolic and diastolic blood pressure in patients with mild essential hypertension. This suggests that both drugs could be viable options for managing hypertension, with similar benefits for patients.

Navigating the Landscape of Hypertension Treatment: Choosing the Right Path

The study offers valuable insights for patients and healthcare providers. The findings suggest that both [nisoldipine] and [propranolol] can be effective options for managing mild essential hypertension. However, individualized patient factors and potential side effects should be considered when determining the most appropriate treatment approach. It is important to consult with your healthcare provider to discuss the risks and benefits of each medication.

Dr. Camel's Conclusion

Just as a caravan navigates the desert landscape, choosing the right path for hypertension treatment requires careful consideration. This study reveals that both [nisoldipine] and [propranolol] can effectively reduce blood pressure, offering patients a choice of routes to manage their condition. It is essential to work closely with your physician to determine the most suitable treatment plan for your specific needs.

Date :
  1. Date Completed 1992-01-14
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2132424

DOI: Digital Object Identifier

2132424

Related Literature

Article Analysis
・Side Effects of nisoldipine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.